British Biotech Giant Leica Biosystems, recently published patent application titled, “Immutable-Ledger-Based Workflow Management For Patient Samples,” has mentioned IOTA blockchain.
Found by: The Librarian
– IOTA Archive — News (@_iotaarchive) June 23, 2021
New Leica’s patent concerns the workflow of the management of samples obtained during microscopic studies.
Leica notes that immutable ledgers are a promising tool used to manage digital assets. In particular, the use of a modification-resistant ledger implemented as a blockchain or directed acyclic graph (DAG) provides accurate and efficient asset tracking.
This technology can also be used with samples, which lately can be used to identify pathogens, make diagnoses, archiving, and other medical purposes.
The authors of the patent application note that the Health Insurance Portability and Accountability Act (HIPAA) which regulates individually identifiable health information assumes that health information related to patients’ specimens shouldn’t be public. A blockchain is a great tool for ensuring privacy specimen tracking.
The workflow management system based on an immutable ledger for patient samples (for example, tissue samples) can use a directed acyclic graph (DAG), which is a hierarchy of nodes without any cycles.
It is designed to work with huge arrays of information. If the network size is small, DAGs are more vulnerable compared to classic blockchains. To add a transaction to a DAG, a user must approve two randomly chosen unconfirmed transactions. In such a system, native tokens can be used, in particular, an example of such use can be IOTA in Tangle.
Originally published at https://thecryptobasic.com on June 23, 2021.
Check out our new platform 👉 https://thecapital.io/
IOTA Is Mentioned in Latest Patent Application of British Biotech Giant Leica Biosystems was originally published in The Capital on Medium, where people are continuing the conversation by highlighting and responding to this story.
This article is strictly for informational purposes only. It is not a direct offer or solicitation of an offer to buy or sell, or a recommendation or endorsement of any products, services, or companies. CryptosOnline.com does not provide investment, tax, legal, business or accounting advice. Neither the company nor the author is responsible, directly or indirectly, for any loss or damage caused or alleged to be caused by, or in connection with, the use of or reliance on any content, goods, services or opinions mentioned in this article.
#Bitcoin #Crypto #Cryptocurrency